Live Quote · NASDAQKYTXHealthcare· Biotechnology

Kyverna Therapeutics, Inc.

$4.48
MKT CAP $283.23M
50%
Bullish
TickerSpark Score
46/100
▌ Weak
70
Valuation
20
Profitability
15
Growth
80
Health

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KYTX research report →

Analyst Price Target
$25.00+458.0% vs. today

Range $25 – $25

Analyst RatingBuy
4 Buy0 Hold0 Sell

Price Chart

-46.90% · this period
$11.25$7.81$4.37Nov 19May 22Nov 19